Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
The Canadian Journal of Cardiology|June 2, 2019
Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal ScreeningGordon A Francis, Liam R Brunham
Trends in Cardiovascular Medicine|May 15, 2020
Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?Liam R Brunham, G B John Mancini
JACC. Case Reports|July 11, 2025
Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene DuplicationMustansir Pindwarawala, Sabyasachi Bose, Liam R Brunham
The Canadian Journal of Cardiology|September 11, 2019
Estimating the Prevalence of Familial Hypercholesterolemia in Acute Coronary Syndrome: A Systematic Review and Meta-analysisAdam I Kramer, Mark Trinder, Liam R Brunham
Canadian Family Physician Medecin De Famille Canadien|February 12, 2026
Advanced therapy in familial hypercholesterolemiaEdward Gao, Liam R Brunham, Ran D Goldman
Current Opinion in Lipidology|March 24, 2025
The need for national and international registries of patients with elevated lipoprotein(a)Adam I Kramer, Iulia Iatan, Liam R Brunham
The Canadian Journal of Cardiology|August 7, 2024
Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid LoweringLiam R Brunham, Eva Lonn, Shamir R Mehta
Current Protocols in Toxicology|August 5, 2017
Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced CardiotoxicityAgnes Maillet, Kim Peng Tan, Liam R Brunham
Journal of the American College of Cardiology|June 3, 2026
The Expanding Oral Options for LDL Cholesterol Management: Ain't No Cholesterol High Enough, Ain't No Target Low Enough!Liam R Brunham, Michael D Shapiro, Vijay Nambi
JAMA Cardiology|February 13, 2020
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular DiseaseMark Trinder, Gordon A Francis, Liam R Brunham
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
The Canadian Journal of Cardiology|June 2, 2019
Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal ScreeningGordon A Francis, Liam R Brunham
Trends in Cardiovascular Medicine|May 15, 2020
Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?Liam R Brunham, G B John Mancini
JACC. Case Reports|July 11, 2025
Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene DuplicationMustansir Pindwarawala, Sabyasachi Bose, Liam R Brunham
The Canadian Journal of Cardiology|September 11, 2019
Estimating the Prevalence of Familial Hypercholesterolemia in Acute Coronary Syndrome: A Systematic Review and Meta-analysisAdam I Kramer, Mark Trinder, Liam R Brunham
Canadian Family Physician Medecin De Famille Canadien|February 12, 2026
Advanced therapy in familial hypercholesterolemiaEdward Gao, Liam R Brunham, Ran D Goldman
Current Opinion in Lipidology|March 24, 2025
The need for national and international registries of patients with elevated lipoprotein(a)Adam I Kramer, Iulia Iatan, Liam R Brunham
The Canadian Journal of Cardiology|August 7, 2024
Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid LoweringLiam R Brunham, Eva Lonn, Shamir R Mehta
Current Protocols in Toxicology|August 5, 2017
Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced CardiotoxicityAgnes Maillet, Kim Peng Tan, Liam R Brunham
Journal of the American College of Cardiology|June 3, 2026
The Expanding Oral Options for LDL Cholesterol Management: Ain't No Cholesterol High Enough, Ain't No Target Low Enough!Liam R Brunham, Michael D Shapiro, Vijay Nambi
JAMA Cardiology|February 13, 2020
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular DiseaseMark Trinder, Gordon A Francis, Liam R Brunham
Pageof 16